63938-5
Type of chemotherapy [PhenX]
Trial
Status Information
- Status
- TRIAL
LOINC Names Get Info
- Fully-Specified Name
- Type of chemotherapy:
Type: Pt: ^Patient: Nom: PhenX - Long Common Name
- Type of chemotherapy [PhenX]
- Short Name
- Type of chemotherapy PhenX
Part Model Get Info
- Component
- Type of chemotherapy
LP114964-2
- Analyte
- Type of chemotherapy
LP114964-2
- Component Numerator
- Type of chemotherapy
LP114964-2
- Component Numerator Core
- Type of chemotherapy
LP114964-2
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Type
LP6886-8
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- ^Patient
LP310005-6
- System Core
- NULL
- Super System
- Patient
LP6985-8
- Scale
- Nom
LP7750-5
- Method
- PhenX
LP95333-8
Survey Question
- Text
- Type of chemo?
- PX071101020502
Normative Answer List: LL1125-5
Source: Consensus measures for Phenotypes and Exposures| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Adriamycin® | 1 | LA14332-3 | |
| Taxol® (Paclitaxel) | 2 | LA14333-1 | |
| Taxotere® (Docetaxel) | 3 | LA14334-9 | |
| Cytoxan® | 4 | LA14335-6 | |
| Xeloda® | 5 | LA14336-4 | |
| Leucovorin® | 6 | LA14337-2 | |
| Fluorouracil® | 7 | LA14338-0 | |
| MethotrexateCopyright http://snomed.info/sct ID:387381009 Methotrexate (substance) | 8 | LA14339-8 | |
| Herceptin® | 9 | LA14340-6 | |
| Avastin® | 10 | LA14341-4 | |
| Aromasin® | 11 | LA14342-2 | |
| Femara® | 12 | LA14343-0 | |
| Other | 13 | LA46-8 |
Basic Attributes
- Class
- PHENX
- Type
- Clinical
- First Released
- Version 2.36
- Last Updated
- Version 2.65 (MIN)
- Change Reason
- Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 62557-4 | PhenX domain - Cancer |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| el-GR | Greek (Greece) | Τύπος χημειοθεραπείας: Synonyms: - Nom PHENX Pt Type Ασθενής Τύπος χημειοθεραπείας Χημειοθεραπεία |
| es-MX | Spanish (Mexico) | Tipo de quimioterapia: |
| it-IT | Italian (Italy) | Tipo di chemioterapia: Synonyms: paziente PhenX Punto nel tempo (episodio) |
| ru-RU | Russian (Russian Federation) | Тип химиотерапии: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 化学疗法类型: Synonyms: Consensus measures for Phenotypes and eXposures; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to https://www.snomed.org/get-snomed or [email protected]<mailto:[email protected]>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://